Boolean analysis identifies CD38 as a biomarker of aggressive localized prostate cancer

The introduction of serum Prostate Specific Antigen (PSA) testing nearly 30 years ago has been associated with a significant shift towards localized disease and decreased deaths due to prostate cancer. Recognition that PSA testing has caused over diagnosis and over treatment of prostate cancer has g...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncotarget
Päätekijät: Sahoo, Debashis, Wei, Wei, Auman, Heidi, Hurtado-Coll, Antonio, Carroll, Peter R., Fazli, Ladan, Gleave, Martin E., Lin, Daniel W., Nelson, Peter S., Simko, Jeff, Thompson, Ian M., Leach, Robin J., Troyer, Dean A., True, Lawrence D., McKenney, Jesse K., Feng, Ziding, Brooks, James D.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Impact Journals LLC 2018
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5814231/
https://ncbi.nlm.nih.gov/pubmed/29464091
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.23973
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia